William Blair & Company acted as exclusive financial advisor to MTS Medication Technologies, a portfolio company of Denver-based Excellere Partners, in conjunction with its sale to Omnicell (NYSE: OMCL) for $156 million. The transaction closed on May 22, 2012.
MTS manufactures automated packaging machines and related consumables for prescription medications and nutritional supplements. MTS serves approximately 6,000 pharmacies worldwide providing medication adherence packaging systems designed to improve medication dispensing and administration.
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automation and business information solutions enabling hospitals and healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside.
Excellere engaged William Blair to assist in the sale of MTS. In conjunction with the engagement, William Blair developed a confidential descriptive memorandum, created a management presentation, marketed the Company to a broad group of global financial and strategic acquirers, coordinated due diligence, drove a highly competitive auction process and negotiated key elements of the definitive purchase agreement.
For additional information about how the investment banking professionals at William Blair can help your business or portfolio company, please visit our website, williamblair.com, or contact us via e-mail at email@example.com.